Affairs of the Heart: Innovation in Cardiovascular Research and Development-Reference-Cited by-同舟云学术

Affairs of the Heart: Innovation in Cardiovascular Research and Development

Published:2017-07-17 Issue:2 Volume:102 Page:162-168
ISSN:0009-9236
Container-title:Clinical Pharmacology & Therapeutics
language:en
Short-container-title:Clin. Pharmacol. Ther.

Author:

Honig P¹,Terzic A²

Affiliation:

1. Collegeville Pennsylvania USA

2. Center for Regenerative Medicine, Departments of Cardiovascular Medicine, Molecular Pharmacology and Experimental Therapeutics, and Medical Genetics; Mayo Clinic; Rochester Minnesota USA

Publisher

Wiley

Subject

Pharmacology (medical),Pharmacology

Reference34 articles.

1. World Health Organization Non-communicable diseases: 2017 Update www.who.int/mediacentre/factsheets/fs355/en/ 2017

2. Chronic diseases: the emerging pandemic;Terzic;Clin. Transl. Sci.,2011

3. American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association;Benjamin;Circulation.,2017

4. Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015;Global Burden of Disease Mortality and Causes of Death Collaborators;Lancet,2016

5. Cardiovascular health: the global challenge;Waldman;Clin. Pharmacol. Ther.,2011

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mass Customized Outlook for Regenerative Heart Failure Care;International Journal of Molecular Sciences;2021-10-22

2. Screening for regenerative therapy responders in heart failure;Biomarkers in Medicine;2021-07

3. New opportunities for targeting redox dysregulation in cardiovascular disease;Cardiovascular Research;2019-07-11

4. Sarcolemmal α2-adrenoceptors in feedback control of myocardial response to sympathetic challenge;Pharmacology & Therapeutics;2019-05

5. Health Care Evolves From Reactive to Proactive;Clinical Pharmacology & Therapeutics;2018-12-29